Skip to main navigation
Skip to search
Skip to main content
University of Portsmouth Home
Help & FAQ
Link opens in a new tab
Search content at University of Portsmouth
Home
Profiles
Organisations
Research outputs
Student theses
Datasets
Projects
Activities
Prizes
Press/Media
Equipment
Shortened peginterferon and ribavirin treatment for chronic hepatitis C
Debbie Hartwell
, Jeremy Jones
, Louise Baxter
, Jonathan Shepherd
University of Southampton
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Shortened peginterferon and ribavirin treatment for chronic hepatitis C'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Peginterferon
100%
Ribavirin
100%
Treatment Duration
100%
Chronic Hepatitis C
100%
Economic Evaluation
66%
Virus Load
66%
Combination Therapy
66%
Quality Adjusted Life Year
33%
Cost Effectiveness Analysis
33%
Cochrane Library
33%
Medline
33%
Embase
33%
Cost Control
33%
Systematic Review
33%
Peginterferon Alpha
33%
Bibliographic Database
33%
INIS
patients
100%
hepatitis
100%
evaluation
50%
cost
50%
range
50%
therapy
50%
economics
50%
viruses
50%
genotype
50%
reviews
25%
comparative evaluations
25%
values
25%
drugs
25%
length
25%
manufacturers
25%
losses
25%
libraries
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ribavirin
100%
Chronic Hepatitis C
100%
Peginterferon
100%
Combination Therapy
66%
Hepatitis C Virus
66%
Pharmaceutical Manufacturing
33%
Randomized Controlled Trial
33%
Peginterferon Alpha
33%